Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)
Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial
Peter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
Neuro-Oncology
|
December 29, 2014
Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes
Arjun Sahgal, Michael W Chan, Eshetu G Atenafu, et al.
Therapeutic Advances in Medical Oncology
|
October 2, 2023
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study
Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
Jeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
European Urology Oncology
|
May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer
Noelia Sanmamed, Ian Dayes, Charles Catton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes
John Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
BMJ Open
|
April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial
Rachel M Glicksman, Ur Metser, John Valliant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 10, 2025
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial
Kara M Ruicci, Aisling Barry, Xiang Y Ye, et al.
Radiology
|
September 10, 2014
MR-guided prostate biopsy for planning of focal salvage after radiation therapy
Cynthia Ménard, Douglas Iupati, Julia Publicover, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)
Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial
Peter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
Neuro-Oncology
|
December 29, 2014
Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes
Arjun Sahgal, Michael W Chan, Eshetu G Atenafu, et al.
Therapeutic Advances in Medical Oncology
|
October 2, 2023
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study
Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
Jeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
European Urology Oncology
|
May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer
Noelia Sanmamed, Ian Dayes, Charles Catton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes
John Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
BMJ Open
|
April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial
Rachel M Glicksman, Ur Metser, John Valliant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 10, 2025
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial
Kara M Ruicci, Aisling Barry, Xiang Y Ye, et al.
Radiology
|
September 10, 2014
MR-guided prostate biopsy for planning of focal salvage after radiation therapy
Cynthia Ménard, Douglas Iupati, Julia Publicover, et al.
Page
of 14